Literature DB >> 25817445

Renal function and dapagliflozin in routine clinical practice.

Thinzar Min1,2, Joel Handley1, David Williams1, David E Price1, Jeffrey W Stephens1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25817445     DOI： 10.1111/1753-0407.12291

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  1 in total

Review 1.  Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus.

Authors:  Paola Fioretto; Andrea Giaccari; Giorgio Sesti
Journal:  Cardiovasc Diabetol       Date:  2015-10-17       Impact factor: 9.951
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.